skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: The palliation of osseous metastasis with sup 32 P or sup 89 Sr compared with external beam and hemibody irradiation: A historical perspective

Journal Article · · Cancer Investigation; (USA)
;  [1]
  1. Indiana Univ. School of Medicine, Indianapolis (USA)

Radiation is an effective modality for palliation of osseous metastases. In patients with a limited number of lesions, local external beam irradiation is the most expedient method of delivering radiation therapy. Complete or partial relief of pain will occur in 80-90% of patients. When metastases are widespread or when new sites continue to appear, localized external irradiation becomes logistically difficult. In such cases, hemibody irradiation has been effective with an overall response rate of 85%. However, nausea, vomiting, diarrhea, and bone marrow and pulmonary toxicity may complicate therapy. In these cases, an effective alternative is systemic phosphorus-32 ({sup 32}P) or strontium-89 ({sup 89}Sr). Relief of pain in the range of 60-90% has been reported. Toxicity of {sup 32}P is largely that of bone marrow suppression, while {sup 89}Sr appears to be relatively marrow-sparing. In this review, we consider systemic {sup 32}P or {sup 89}Sr as viable options to external beam or hemibody irradiation in the presence of numerous bone metastases. 105 references.

OSTI ID:
5157165
Journal Information:
Cancer Investigation; (USA), Vol. 7:2; ISSN 0735-7907
Country of Publication:
United States
Language:
English